Trial Profile
[18F]Fluorothymidine (FLT) PET/CT Imaging in Rb+ Metastatic Breast Cancer Patients Undergoing LEE011 and Weekly Paclitaxel Therapy
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 28 Aug 2023
Price :
$35
*
At a glance
- Drugs Ribociclib (Primary) ; Paclitaxel
- Indications Advanced breast cancer
- Focus Pharmacodynamics
- 23 Aug 2023 Planned End Date changed from 1 Nov 2023 to 1 Nov 2024.
- 23 Aug 2023 Planned primary completion date changed from 1 Nov 2023 to 1 Nov 2024.
- 16 Aug 2022 Planned End Date changed from 1 Nov 2022 to 1 Nov 2023.